Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Cerami

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Annals of Clinical and Translational Neurology|August 8, 2020
<sup>11</sup> C-PK11195 PET-based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosisGiacomo Tondo, Leonardo Iaccarino, Chiara Cerami, et al.
Neuroinformatics|June 23, 2014
A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementiaPasquale Anthony Della Rosa, Chiara Cerami, Francesca Gallivanone, et al.
Neuroimage. Clinical|February 2, 2018
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohortSilvia Paola Caminiti, Tommaso Ballarini, Arianna Sala, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2019
Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosisArianna Sala, Leonardo Iaccarino, Piercarlo Fania, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 8, 2022
Answer to "Social cognition assessment for mild neurocognitive disorders"Alessandra Dodich, Marina Boccardi, Leonardo Sacco, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2015
Erratum to: Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical settingDaniela Perani, Chiara Cerami, Silvia Paola Caminiti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2015
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical settingDaniela Perani, Chiara Cerami, Silvia Paola Caminiti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 17, 2012
Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degenerationDaniela Galimberti, Claudio D'Addario, Bernardo Dell'osso, et al.
Neuroimage. Clinical|November 13, 2014
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical settingDaniela Perani, Pasquale Anthony Della Rosa, Chiara Cerami, et al.
Aging Clinical and Experimental Research|May 14, 2025
Targeting brain health in subjective cognitive decline: insights from a multidomain randomized controlled trialElena Rolandi, Alessandra Dodich, Sara Mandelli, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Annals of Clinical and Translational Neurology|August 8, 2020
<sup>11</sup> C-PK11195 PET-based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosisGiacomo Tondo, Leonardo Iaccarino, Chiara Cerami, et al.
Neuroinformatics|June 23, 2014
A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementiaPasquale Anthony Della Rosa, Chiara Cerami, Francesca Gallivanone, et al.
Neuroimage. Clinical|February 2, 2018
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohortSilvia Paola Caminiti, Tommaso Ballarini, Arianna Sala, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2019
Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosisArianna Sala, Leonardo Iaccarino, Piercarlo Fania, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 8, 2022
Answer to "Social cognition assessment for mild neurocognitive disorders"Alessandra Dodich, Marina Boccardi, Leonardo Sacco, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2015
Erratum to: Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical settingDaniela Perani, Chiara Cerami, Silvia Paola Caminiti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2015
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical settingDaniela Perani, Chiara Cerami, Silvia Paola Caminiti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 17, 2012
Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degenerationDaniela Galimberti, Claudio D'Addario, Bernardo Dell'osso, et al.
Neuroimage. Clinical|November 13, 2014
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical settingDaniela Perani, Pasquale Anthony Della Rosa, Chiara Cerami, et al.
Aging Clinical and Experimental Research|May 14, 2025
Targeting brain health in subjective cognitive decline: insights from a multidomain randomized controlled trialElena Rolandi, Alessandra Dodich, Sara Mandelli, et al.
Pageof 10